Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 4
2020 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean b navaei (2 results)?
Device use errors with soft mist inhalers: A global systematic literature review and meta-analysis.
Navaie M, Dembek C, Cho-Reyes S, Yeh K, Celli BR. Navaie M, et al. Chron Respir Dis. 2020 Jan-Dec;17:1479973119901234. doi: 10.1177/1479973119901234. Chron Respir Dis. 2020. PMID: 31984767 Free PMC article.
PubMed, EMBASE, PsycINFO, Cochrane, and Google Scholar were searched to identify studies published between 2010 and 2019 that met the following inclusion criteria: (a) English language; (b) a diagnosis of COPD, bronchitis, or emphysema; and (c) reported device use errors a …
PubMed, EMBASE, PsycINFO, Cochrane, and Google Scholar were searched to identify studies published between 2010 and 2019 that met the follow …
Inhalation Technique Errors with Metered-Dose Inhalers Among Patients with Obstructive Lung Diseases: A Systematic Review and Meta-Analysis of U.S. Studies.
Cho-Reyes S, Celli BR, Dembek C, Yeh K, Navaie M. Cho-Reyes S, et al. Chronic Obstr Pulm Dis. 2019 Jul 24;6(3):267-280. doi: 10.15326/jcopdf.6.3.2018.0168. Chronic Obstr Pulm Dis. 2019. PMID: 31342732 Free PMC article. Review.
METHODS: Electronic and manual searches conducted between 1979-2018 using PubMed, EMBASE, PsycINFO, Cochrane, and Google identified 10 articles that met the following inclusion criteria: (a) English language, (b) U.S. adults diagnosed with chronic obstructive pulmonary dis …
METHODS: Electronic and manual searches conducted between 1979-2018 using PubMed, EMBASE, PsycINFO, Cochrane, and Google identified 10 artic …
Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease.
Gilmer TP, Celli BR, Xu Z, Cho-Reyes S, Dembek C, Navaie M. Gilmer TP, et al. COPD. 2019 Apr;16(2):140-151. doi: 10.1080/15412555.2019.1618256. Epub 2019 Jun 19. COPD. 2019. PMID: 31215259 Free article.
Inclusion criteria required 1 COPD medication claim(s) and continuous enrollment in Parts A, B, and D. Four cohorts were identified: (a) 11,887 arformoterol users, (b) a subsample of arformoterol users (n = 1,778) who were hospitalized and discharged 30 d before in …
Inclusion criteria required 1 COPD medication claim(s) and continuous enrollment in Parts A, B, and D. Four cohorts were identified: …
Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease Treated with Nebulized Arformoterol Following a Respiratory Event.
Navaie M, Celli BR, Xu Z, Cho-Reyes S, Dembek C, Gilmer TP. Navaie M, et al. Chronic Obstr Pulm Dis. 2019 Oct 23;6(4):297-307. doi: 10.15326/jcopdf.6.4.2019.0127. Chronic Obstr Pulm Dis. 2019. PMID: 31483988 Free PMC article.
METHODS: Using Medicare claims, we identified beneficiaries with COPD (international classification of disease, 9th revision, clinical modification [ICD-9-CM] 490-492.xx, 494.xx, 496.xx) between 2010-2014 who had 1 year of continuous enrollment in Parts A, B, and D; 2 …
METHODS: Using Medicare claims, we identified beneficiaries with COPD (international classification of disease, 9th revision, clinical modif …
Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment.
Celli BR, Navaie M, Xu Z, Cho-Reyes S, Dembek C, Gilmer TP. Celli BR, et al. Int J Chron Obstruct Pulmon Dis. 2019 May 15;14:1019-1031. doi: 10.2147/COPD.S199251. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31190787 Free PMC article.
Methods: Using a 100% sample of Medicare administrative data, we identified beneficiaries with a COPD diagnosis (ICD-9 490-492.xx, 494.xx, 496.xx) between 2010 and 2014 who had 1 year of continuous enrollment in Parts A, B, and D, and 2 COPD-related outpatient visits wit …
Methods: Using a 100% sample of Medicare administrative data, we identified beneficiaries with a COPD diagnosis (ICD-9 490-492.xx, 494.xx, 4 …